UK Markets close in 2 hrs 25 mins

Global NGS Oncology Market Report 2022-2032: Increasing Incidence of Cancer Requiring Sophisticated Molecular Techniques Driving Growth

·2-min read
Company Logo
Company Logo

Global NGS Oncology Market

Global NGS Oncology Market
Global NGS Oncology Market

Dublin, July 13, 2022 (GLOBE NEWSWIRE) -- The "NGS Oncology Market - A Global and Regional Analysis: Focus on Offering, Sequencing Technology, Workflow, Application, End User, and Region - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.

Global NGS Oncology Market Industry Overview

The global NGS oncology market is projected to reach $51,783.0 million in 2032 from 14,828.6 million in 2021, witnessing a CAGR of 12.04% during the forecast period 2022-2032. The growth in the NGS oncology market is expected to be driven by an increasing number of panels or kits, bioinformatics services for computational analysis, and a rising number of open-source free sequencing platform providers offering NGS oncology.

Market Segmentation
by Sequencing Technology

  • Targeted Sequencing

  • Genomics

  • Transcriptomics

  • Epigenomics

by Offering

  • Platform

  • Kits

  • Services

by Workflow

  • Pre-Sequencing

  • Sequencing

  • Data Analysis

by Application

  • Genetic Screening

  • Hereditary Genetic Testing

  • Hematological Malignancies

  • Solid Tumors

  • Other Applications

by End User

  • Hospitals and Clinics

  • Clinical Research Organizations (CROs)

  • Academic and Research Institutes

  • Pharmaceutical and Biotechnology Companies

  • Other End Users

Demand - Drivers and Limitations
Following are the demand drivers for the global NGS Oncology Market:

  • Increasing Incidence of Cancer Requiring Sophisticated Molecular Techniques

  • Reducing Cost of Sequencing

  • Rapid Technological Advancements Related to NGS Oncology

The market is expected to face some limitations too due to the following challenges:

  • Inadequate NGS Oncology Reimbursement Scenario

  • Increasing Cost of NGS Automated Sample Preparation Instruments

  • Barriers in the Advancement of NGS Oncology

Key Market Players and Competition Synopsis

  • Agilent Technologies, Inc.

  • Bio-Rad Laboratories, Inc.

  • Biodesix, Inc.

  • Caris Life Sciences

  • DNASTAR

  • Fulgent Genetics, Inc.

  • F. Hoffmann-La Roche Ltd

  • Illumina, Inc.

  • Invitae Corporation

  • IntegraGen (OncoDNA)

  • Oxford Nanopore Technologies plc.

  • Pacific Biosciences of California, Inc.

  • PerkinElmer, Inc.

  • Pillar Biosciences, Inc.

  • QIAGEN N.V.

  • Thermo Fisher Scientific Inc.

  • Takara Bio Inc.

  • Vela Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/nd4kcu

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting